DE602004010691D1 - Verwendung von xenon mit hypothermie zur behandlung von neugeborenen-asphyxie - Google Patents

Verwendung von xenon mit hypothermie zur behandlung von neugeborenen-asphyxie

Info

Publication number
DE602004010691D1
DE602004010691D1 DE602004010691T DE602004010691T DE602004010691D1 DE 602004010691 D1 DE602004010691 D1 DE 602004010691D1 DE 602004010691 T DE602004010691 T DE 602004010691T DE 602004010691 T DE602004010691 T DE 602004010691T DE 602004010691 D1 DE602004010691 D1 DE 602004010691D1
Authority
DE
Germany
Prior art keywords
hypothermia
xenon
treatment
asphyxia
newborn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004010691T
Other languages
English (en)
Other versions
DE602004010691T2 (de
Inventor
Nicholas Franks
Mervyn Maze
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Protexeon Ltd
Original Assignee
Protexeon Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34436835&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602004010691(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0323861A external-priority patent/GB0323861D0/en
Priority claimed from GB0418539A external-priority patent/GB0418539D0/en
Application filed by Protexeon Ltd filed Critical Protexeon Ltd
Publication of DE602004010691D1 publication Critical patent/DE602004010691D1/de
Application granted granted Critical
Publication of DE602004010691T2 publication Critical patent/DE602004010691T2/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
DE602004010691T 2003-10-10 2004-10-11 Verwendung von xenon mit hypothermie zur behandlung von neugeborenen-asphyxie Active DE602004010691T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0323861A GB0323861D0 (en) 2003-10-10 2003-10-10 Use
GB0323861 2003-10-10
GB0418539A GB0418539D0 (en) 2004-08-19 2004-08-19 Use
GB0418539 2004-08-19
PCT/GB2004/004298 WO2005034966A1 (en) 2003-10-10 2004-10-11 Use of xenon with hypothermia for treating neonatal asphyxia

Publications (2)

Publication Number Publication Date
DE602004010691D1 true DE602004010691D1 (de) 2008-01-24
DE602004010691T2 DE602004010691T2 (de) 2008-12-04

Family

ID=34436835

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004010691T Active DE602004010691T2 (de) 2003-10-10 2004-10-11 Verwendung von xenon mit hypothermie zur behandlung von neugeborenen-asphyxie

Country Status (13)

Country Link
US (1) US7390508B2 (de)
EP (1) EP1670489B1 (de)
JP (1) JP4880466B2 (de)
AT (1) ATE380554T1 (de)
AU (1) AU2004280118B2 (de)
BR (1) BRPI0415232A (de)
CA (1) CA2538104C (de)
DE (1) DE602004010691T2 (de)
DK (1) DK1670489T3 (de)
ES (1) ES2298815T3 (de)
MX (1) MXPA06003471A (de)
PT (1) PT1670489E (de)
WO (1) WO2005034966A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4880466B2 (ja) * 2003-10-10 2012-02-22 プロテクソン リミテッド 新生児仮死を治療するための低体温療法におけるキセノンの使用
GB0418540D0 (en) 2004-08-19 2004-09-22 Protexeon Ltd Use
GB0520176D0 (en) * 2005-10-04 2005-11-09 Imp College Innovations Ltd Use
ITMI20071031A1 (it) * 2007-05-22 2008-11-23 Acetilene & Deriv Ati Siad Spa Uso di xenon per la protezione di organi da danno ischemico
AU2014277860A1 (en) * 2008-01-22 2015-01-22 Board Of Regents, The University Of Texas System Volatile anesthetic compositions and methods of use
WO2009094460A2 (en) 2008-01-22 2009-07-30 Vapogenix, Inc. Volatile anesthetic compositions and methods of use
JP2012526133A (ja) * 2009-05-05 2012-10-25 ベイポジェニックス インコーポレイテッド 炎症を低減させるための新規揮発性麻酔薬製剤およびその使用法
CN110464709A (zh) 2012-08-10 2019-11-19 德克萨斯州大学系统董事会 用于治疗中风的神经保护性脂质体组合物和方法
AU2014233018A1 (en) 2013-03-15 2015-10-01 The Board Of Regents Of The University Of Texas System Liquids rich in noble gas and methods of their preparation and use
FR3021220B1 (fr) * 2014-05-21 2017-08-25 Air Liquide Association de xenon et d’un antioxydant pour lutter contre une maladie neurodegenerative de type maladie de parkinson
JP6622822B2 (ja) * 2015-06-23 2019-12-18 ノビリス セラピューティクス インコーポレイテッド 希ガス組成物を用いた治療的な免疫調節
US10022397B2 (en) * 2016-06-20 2018-07-17 Nobilis Therapeutics, Inc. Treatment of rheumatoid arthritis using noble gas mixtures

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5099834A (en) * 1991-07-16 1992-03-31 Union Carbide Industrial Gases Technology Corporation Method for anesthesia
DE19709704C2 (de) * 1997-03-10 1999-11-04 Michael Georgieff Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
DE19910986C2 (de) * 1999-03-11 2001-06-07 Aga Ab Verwendung von Xenon bei der Behandlung von Neurointoxikationen
DE19933704A1 (de) 1999-07-19 2001-01-25 Michael Georgieff Verwendung einer lipophile Gase enthaltenden Präparation zur Neuroprotektion und Neuroregeneration
GB9917822D0 (en) * 1999-07-29 1999-09-29 Imperial College Nmda antagonist
US6653354B2 (en) 1999-07-29 2003-11-25 Protexeon Limited NMDA antagonist comprising xenon
JP2003530185A (ja) * 2000-03-31 2003-10-14 インナークール セラピーズ， インコーポレイテッド 医療法
JP4880466B2 (ja) * 2003-10-10 2012-02-22 プロテクソン リミテッド 新生児仮死を治療するための低体温療法におけるキセノンの使用

Also Published As

Publication number Publication date
CA2538104A1 (en) 2005-04-21
JP4880466B2 (ja) 2012-02-22
WO2005034966A1 (en) 2005-04-21
MXPA06003471A (es) 2006-06-14
PT1670489E (pt) 2008-02-28
AU2004280118A1 (en) 2005-04-21
DE602004010691T2 (de) 2008-12-04
US7390508B2 (en) 2008-06-24
US20070104796A1 (en) 2007-05-10
AU2004280118B2 (en) 2009-01-15
CA2538104C (en) 2013-12-10
ATE380554T1 (de) 2007-12-15
ES2298815T3 (es) 2008-05-16
DK1670489T3 (da) 2008-01-07
BRPI0415232A (pt) 2006-12-12
EP1670489B1 (de) 2007-12-12
JP2007508284A (ja) 2007-04-05
EP1670489A1 (de) 2006-06-21

Similar Documents

Publication Publication Date Title
ATE449602T1 (de) Arzneimittel mit dobesilat-calcium zur behandlung und prophylaxe von sehnenerkrankungen
ATE512663T1 (de) Kombination zur behandlung von erkrankungen mit zellproliferation
ATE438623T1 (de) Aroyl-o-piperidinderivate zur behandlung von problemen im zusammenhang mit diabetes
ATE395871T1 (de) Marknagel zur behandlung von proximalen oberschenkelknochenbrüchen
DE602005001929D1 (de) Sulfonamidderivate zur behandlung von krankheiten
ATE390407T1 (de) Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
ATE417037T1 (de) Diarylharnstoffderivate, die sich zur behandlung von proteinkinaseabhängigen krankheiten eignen
DE602005024571D1 (de) Opioide zur behandlung von ruhelosigkeit in den unteren gliedmassen
ATE447551T1 (de) Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
DE60236413D1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
ATE473735T1 (de) Beta-2 adrenoceptor agonisten zur behandlung von bindegewebserkrankungen der haut
EA200700637A1 (ru) Соли донепезила, подходящие для получения фармацевтических композиций
EA200700407A1 (ru) Производные хиназолина и их использования при лечении тромбоцитемии
ATE464895T1 (de) Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von depressionen
DE602004010691D1 (de) Verwendung von xenon mit hypothermie zur behandlung von neugeborenen-asphyxie
ATE247507T1 (de) Verwndung von verbindungen mit 5-ht1a aktivität zur behandlung von krankheiten der äusseren retina
ATE510536T1 (de) Verwendung von 2,5-dihydroxybenzol-derivaten zur behandlung von reaktiven gewebeerkrankungen
DE502005003840D1 (de) Anlage zur nichtinvasiven medizinischen behandlung
EA200970345A1 (ru) Лечение гипербилирубинемии новорожденных с использованием низких дозировок станнсопорфина
ATE304854T1 (de) Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne
DE602005013542D1 (de) Behandlung der oralen und darm mukositis durch verabreichung von menschlichem il-18
ATE330596T1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
ATE482707T1 (de) 1-ä2h-1-benzopyran-2-on-8-ylü- piperazin- derivate zur behandlung von schmerzen
ATE477820T1 (de) Pharmazeutische zusammensetzungen zur oralen verabreichung bei der behandlung von adipositas- patienten

Legal Events

Date Code Title Description
8363 Opposition against the patent
8381 Inventor (new situation)

Inventor name: FRANKS, NICHOLAS PETER, LONDON SW7 2BZ, GB

Inventor name: MAZE, MERVYN, LONDON SW10 9NH, GB